Skip to main content

Advertisement

SpringerLink
Log in

VEGF-C and VEGFR-3 in a series of lymphangiomas: Is superficial lymphangioma a true lymphangioma?

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Lymphangiomas are commonly regarded as vascular malformations during embryonic development rather than as true neoplasms. VEGF-C and VEGFR-3 are known to be active in the formation of lymphangiomas. However, the significance of the disorders seems to be obscured by confusing different entities. In 114 lymphangiomas, we investigated the clinicopathological features and the expression of VEGF-C and VEGFR-3. The age of patients with lymphangioma circumscriptum or intraabdominal lymphangioma was significantly higher than in patients with cavernous lymphangioma and in patients with cystic hygroma. In cavernous lymphangioma, the age of female patients was significantly higher than in male patients. Five adult cystic hygromas were identified. VEGF-C was detected in 21 of 58 (36%) cavernous lymphangiomas, ten of 28 (36%) cystic hygromas, 0 of 12 (0%) lymphangioma circumscriptum, and four of ten (40%) intraabdominal lymphangiomas. VEGFR-3 was detected in 43 of 58 (72%) cavernous lymphangiomas, 20 of 28 (71%) cystic hygromas, six of 12 (50%) lymphangiomas circumscriptum, and seven of ten (70%) intraabdominal lymphangiomas. VEGF-C was absent from superficial lymphangiomas associated with cavernous lymphangiomas. In typical cases of cavernous lymphangioma, VEGF-C was strongly expressed, suggesting that these cases possessed proliferative activity. In cystic hygroma and intraabdominal lymphangioma, VEGF-C was limited in its distribution. Superficial lymphangiomas more likely represent from peripheral lymphatic dilatation rather than due to growth factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Takahashi K, Mulliken JB, Kozakewich HP et al (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93:2357–2364

    Article  PubMed  CAS  Google Scholar 

  2. Boye E, Yu Y, Paranya G et al (2001) Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745–752

    Article  PubMed  CAS  Google Scholar 

  3. Khan ZA, Melero-Martin JM, Wu X et al (2006) Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108:915–921

    Article  PubMed  CAS  Google Scholar 

  4. Weiss SW, Goldblum JR (2001) Enzinger and Weiss’s soft tissue tumors, 4th edn. Mosby. St. Louis, MO

    Google Scholar 

  5. Flanagan BP, Helwig EB (1977) Cutaneous lymphangioma. Arch Dermatol 113:24–30

    Article  PubMed  CAS  Google Scholar 

  6. Diaz-Cascajo C, Borghi S, Weyers W et al (1999) Benign lymphangiomatous papules of the skin following radiotherapy: a report of five new cases and review of the literature. Histopathology 35:319–327

    Article  PubMed  CAS  Google Scholar 

  7. Sangeza OP, Requena L (2003) Pathology of vascular skin lesions: clinicopathological correlations. Humana, Totowa, NJ

    Book  Google Scholar 

  8. Oliver G, Alitalo K (2005) The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 21:457–483

    Article  PubMed  CAS  Google Scholar 

  9. Cueni LN, Detmar M (2006) New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 126:2167–2177

    Article  PubMed  CAS  Google Scholar 

  10. Kaipainen A, Korhonen J, Mustonen T et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92:3566–3570

    Article  PubMed  CAS  Google Scholar 

  11. Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425

    Article  PubMed  CAS  Google Scholar 

  12. Stacker SA, Achen MG, Jussila L et al (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573–583

    Article  PubMed  CAS  Google Scholar 

  13. Huang HY, Ho CC, Huang PH et al (2001) Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Lab Invest 81:1729–1734

    PubMed  CAS  Google Scholar 

  14. Norgall S, Papoutsi M, Rossler J et al (2007) Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer 7:105

    Article  PubMed  CAS  Google Scholar 

  15. Kasten P, Schnöink G, Bergmann A et al (2007) Similarities and differences of human and experimental mouse lymphangiomas. Dev Dyn 236:2952–2961

    Article  PubMed  Google Scholar 

  16. Saito T, Terada K, Tsuchiya K et al (1999) Lymphangioma presenting as a dumbbell tumor in the epidural space of the lumbar spine. Spine 24:74–76

    Article  PubMed  CAS  Google Scholar 

  17. Itakura E, Yamamoto H, Oda Y et al (2008) Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 97:74–81

    Article  PubMed  Google Scholar 

  18. Wilcox RR (2005) Introduction to robust estimation and hypothesis testing, 2nd edn. Elsevier, Burlington, MA

    Google Scholar 

  19. Lymboussaki A, Olofsson B, Eriksson U et al (1999) Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Circ Res 85:992–999

    PubMed  CAS  Google Scholar 

  20. Mäkinen T, Veikkola T, Mustjoki S et al (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762–4773

    Article  PubMed  Google Scholar 

  21. Pytowski B, Goldman J, Persaud K et al (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14–21

    Article  PubMed  CAS  Google Scholar 

  22. Dumont DJ, Jussila L, Taipale J et al (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946–949

    Article  PubMed  CAS  Google Scholar 

  23. Partanen TA, Alitalo K, Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86:2406–2412

    Article  PubMed  CAS  Google Scholar 

  24. Folpe AL, Veikkola T, Valtola R et al (2000) Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, Kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 13:180–185

    Article  PubMed  CAS  Google Scholar 

  25. Skobe M, Brown LF, Tognazzi K et al (1999) Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi’s sarcoma. J Invest Dermatol 113:1047–1053

    Article  PubMed  CAS  Google Scholar 

  26. Galambos C, Nodit L (2005) Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol 8:181–189

    Article  PubMed  Google Scholar 

  27. Chervenak FA, Isaacson G, Blakemore KJ et al (1983) Fetal cystic hygroma. Cause and natural history. N Engl J Med 309:822–825

    PubMed  CAS  Google Scholar 

  28. Ganapathy R, Guven M, Sethna F et al (2004) Natural history and outcome of prenatally diagnosed cystic hygroma. Prenat Diagn 24:965–968

    Article  PubMed  CAS  Google Scholar 

  29. Gedikbasi A, Gul A, Sargin A et al (2007) Cystic hygroma and lymphangioma: associated findings, perinatal outcome and prognostic factors in live-born infants. Arch Gynecol Obstet 276:491–498

    Article  PubMed  Google Scholar 

  30. Goodman J, McClintock J, Denton GR et al (1963) Cystic hygromas in adults. Arch Surg 86:641–644

    PubMed  CAS  Google Scholar 

  31. Nussbaum M, Buchwald RP (1981) Adult cystic hygroma. Am J Otolaryngol 2:159–162

    Article  PubMed  CAS  Google Scholar 

  32. Baer S, Davis J (1989) Cystic hygroma presenting in adulthood. J Laryngol Otol 103:976–977

    Article  PubMed  CAS  Google Scholar 

  33. Gleason TJ, Yuh WTC, Tali ET et al (1993) Traumatic cervical cystic lymphangioma in an adult. Ann Otol Rhinol Laryngol 102:564–566

    PubMed  CAS  Google Scholar 

  34. Morley SE, Ramesar KCRB, Macleod DAD (1999) Cystic hygroma in an adult: a case report. J R Coll Surg Edinb 44:57–58

    PubMed  CAS  Google Scholar 

  35. Leipzig B, Rabuzzi DD (1978) Recurrent massive cystic lymphangioma. Otolaryngology 86:758–760

    Google Scholar 

  36. Scally CM, Black JH (1990) Cystic hygroma: massive recurrence in adult life. J Laryngol Otol 104:908–910

    Article  PubMed  CAS  Google Scholar 

  37. Peachey RD, Lim CC, Whimster IW (1970) Lymphangioma of skin. A review of 65 cases. Br J Dermatol 83:519–527

    Article  PubMed  CAS  Google Scholar 

  38. Russell B, Pridie RB (1967) Lymphangioma circumscriptum with involvement of deep lymphatics. Br J Dermatol 79:300

    Google Scholar 

  39. Mahle C, Schwartz M, Popek E et al (1997) Intra-abdominal lymphangiomas in children and adults. Assessment of proliferative activity. Arch Pathol Lab Med 121:1055–1062

    PubMed  CAS  Google Scholar 

  40. Brown M, Pysher T, Coffin CM (1999) Lymphangioma and congenital pulmonary lymphangiectasis: a histologic, immunohistochemical, and clinicopathologic comparison. Mod Pathol 12:569–575

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors would like to thank Dr. Walter F. Coulson, Emeritus Professor, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, for reviewing and editing the manuscript.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Author notes

  1. Eijun Itakura

    Present address: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, CHS 1P-162, Los Angeles, CA, 90095-1732, USA

Authors and Affiliations

  1. Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Eijun Itakura, Hidetaka Yamamoto, Yoshinao Oda & Masazumi Tsuneyoshi

  2. Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Eijun Itakura & Masutaka Furue

Authors
  1. Eijun Itakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hidetaka Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshinao Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masutaka Furue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masazumi Tsuneyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshinao Oda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itakura, E., Yamamoto, H., Oda, Y. et al. VEGF-C and VEGFR-3 in a series of lymphangiomas: Is superficial lymphangioma a true lymphangioma?. Virchows Arch 454, 317–325 (2009). https://doi.org/10.1007/s00428-008-0720-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-008-0720-8

Keywords

Search

Navigation